Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Online Support for Pathologists

By HospiMedica staff writers
Posted on 09 Jun 2006
A new online resource is designed to enable pathologists to make quicker, more accurate diagnoses.

Called Path Consult, the new resource was launched by Elsevier (Amsterdam, The Netherlands), a leading scientific, technical, and healthcare publisher. More...
Path Consult can be used in the workplace as a differential diagnosis tool to provide clinical decision support in every subspecialty area of general pathology. For the first time, pathologists will be able to conduct a side-by-side comparison of up to three diagnoses at a time, significantly reducing the amount of time spent researching the same information off-line.

Path Consult demonstrates Elsevier's commitment to customers by delivering a truly innovative tool for the end user. Our agile development process is designed to maximize this value in minimum time, said Jonathan Clark, executive vice president, technology, at Elsevier.

Using its established industry-leading references from the publishing firm Mosby, Saunders, and Churchill Livingstone, Elsevier developed Path Consult to include more than 10,000 images for more than 500 conditions at launch, which will grow to more than 20,000 images for 1,200 diagnoses by the fall of 2006. Path Consult was developed using a development process that closely engaged development partners so Elsevier could quickly bring the product to market with the features pathologists really want. The agile process involves a series of product iterations, which are adapted based on feedback.

Elsevier worked with leading pathologists to ensure the quality, accuracy, and usability of the online resource. A plethora of expertly obtained digital images and succinct textual content combined with the ability to compare similar histopathologic entities at the touch of a button will make the job of any pathologist easier, observed John D. Cochran, M.D., a private practice pathologist in Atlanta (GA, USA) who worked with Elsevier on the development of the product.

Elsevier noted that group practices and institutions can sign up for a free trial at the website.



Related Links:
Elsevier
Path Consult

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.